Advanced Enzyme Technologies Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Advanced Enzyme Technologies Limited - overview
Established
1989
Location
Thane, -, India
Primary Industry
Biotechnology
About
Founded in 1989 and based in Thane, India, Advanced Enzyme Technologies Limited operates as a manufacturer of enzymes and probiotics used for health care, nutrition, food and beverage processing, dairy processing, textile processing, and leather processing.
Current Investors
OrbiMed Advisors, Nalanda Capital Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.advancedenzymes.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Advanced Enzyme Technologies Limited - timeline of key events
Advanced Enzyme Technologies Limited - financials
| Fiscal Year Ended | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,204,184,629 | 2,394,500,000 | 2,231,140,000 | 2,937,620,000 | 3,313,590,000 | 3,956,990,000 | 4,195,910,000 | 4,439,860,000 | 5,018,410,000 | - | - | - |
| % Revenue Growth (YoY) | - | 8.6% | (6.8%) | 31.7% | 12.8% | 19.4% | 6.0% | 5.8% | 13.0% | - | - | - |
| EBITDA (USD) | 923,689,633 | 510,350,000 | 926,380,000 | 1,342,920,000 | 1,526,210,000 | 1,638,020,000 | 1,866,040,000 | 2,076,110,000 | 2,398,020,000 | - | - | - |
| Operating Income (USD) | 849,389,936 | 410,530,000 | 836,210,000 | 1,255,730,000 | 1,404,120,000 | 1,455,040,000 | 1,654,880,000 | 1,818,330,000 | 2,113,800,000 | - | - | - |
| Operating Margin | 38.5% | 17.1% | 37.5% | 42.7% | 42.4% | 36.8% | 39.4% | 41.0% | 42.1% | - | - | - |
| % EBITDA Margin | 41.9% | 21.3% | 41.5% | 45.7% | 46.1% | 41.4% | 44.5% | 46.8% | 47.8% | - | - | - |
| NET Income (USD) | 508,763,926 | 210,050,000 | 518,130,000 | 767,460,000 | 923,620,000 | 935,560,000 | 1,159,030,000 | 1,330,490,000 | 1,514,640,000 | - | - | - |
| % Net Margin | 23.1% | 8.8% | 23.2% | 26.1% | 27.9% | 23.6% | 27.6% | 30.0% | 30.2% | - | - | - |
Advanced Enzyme Technologies Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | SciTech Specialities Pvt. Ltd. | - | ||||||||
| PIPE | Completed | Advanced Enzyme Technologies Limited | - | ||||||||
| PIPE | Completed | Advanced Enzyme Technologies Limited | - | ||||||||
| Private Debt | Completed | Advanced Enzyme Technologies Limited | - | ||||||||
| Private Placement/Follow on | Completed | Advanced Enzyme Technologies Limited | - |
Displaying 1 - 5 of 7
Advanced Enzyme Technologies Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.